Capital expenditure decreased 56.3%
Capital expenditure changed -56.3% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure changed -56.3% from the comparable as-filed period. The change ranks at the 100th percentile of 6 prior comparable changes.
Operating margin changed -193 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Stock-based compensation changed +75.0% from the comparable as-filed period. The change ranks at the 83th percentile of 6 prior comparable changes.
Revenue changed +10.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -982 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.